High Patient Satisfaction with Telemedicine Visits for Plastic Surgery Follow-Up
Telemedicine programs provide an effective alternative to in-person clinic visits for follow-up evaluation after plastic surgery procedures for patients in rural areas, reports a study in the August issue of Plastic and Reconstructive Surgery®, the official medical journal of the American Society of Plastic Surgeons (ASPS).
"While initially hesitant to opt for a telehealth encounter in lieu of a traditional clinic visit, the great majority of patients voiced satisfaction with the telehealth experience," according to the Plastic Surgery Focus article by ASPS Member Surgeon John F. Nigriny, MD, of Dartmouth-Hitchcock Medical Center, Lebanon, N.H., and colleagues.
Study Extends Telemedicine Approach to Rural Patients after Plastic Surgery
Dr. Nigriny and coauthors report the development and initial evaluation of a telemedicine system to improve access to follow-up evaluation after plastic and reconstructive surgery procedures for patients in rural areas. In preoperative surveys, the authors found that one-half of patients treated at their plastic surgery department had to travel at least 30 minutes for clinic visits.
Borrowing a quality improvement and defect reduction process that has proven effective in the business and manufacturing sectors (the Lean Six Sigma framework), the researchers developed a "testable workflow" for telehealth visits. This process addressed a wide range of issues to optimize clinical efficiency for remote follow-up evaluations, including cellular phone network requirements (at least 2G) and a secure, encrypted videoconferencing system.
On the day of the telemedicine sessions, a visiting nurse with specialty certification in wound care traveled to the patient's home. The visiting nurse used an iPad to enable visual examination and communication between the plastic surgeon and patient. The nurse was present to perform hands-on tasks like changing dressings and removing sutures.
The evaluation included 72 patients who underwent telemedicine visits for follow-up evaluation after non-cosmetic plastic surgery procedures. The patients lived in rural areas of New Hampshire or Vermont, with an average travel time of 30 to 60 minutes to the medical center.
In an initial survey, nearly three-fourths of patients said they would prefer a traditional, in-person visit for follow-up evaluation. Younger patients were more likely to say they felt comfortable with the telemedicine technology.
But in a follow-up survey, nearly all patients expressed satisfaction with their telemedicine visit. Ninety-six percent said they were able to get all their questions answered during the visit, and that they would use the telehealth option for future follow-up care.
Telemedicine is an emerging option for providing clinical information and enabling discussion between healthcare providers and patients. Although it has been shown to have benefits for patients with conditions such as diabetes and high blood pressure, "there is still uncertainty about the effectiveness of telemedicine in specific clinical situations," Dr. Nigriny and coauthors write.
Their experience demonstrates that an effective and clinically efficient telemedicine system can be developed for plastic surgery follow-up evaluations. "The addition of a telemedicine-based approach is associated with improved patient satisfaction, reduction of hospital costs, and potentially improved clinical outcomes," the researchers conclude.
"These results show that plastic surgery telehealth can enable real-time clinical decision-making, expand access to providers, and decrease patient travel and wait times," according to a video commentary by Plastic and Reconstructive Surgery Editor-in-Chief Rod J. Rohrich, MD. He adds, "Telemedicine programs like this could improve healthcare access in underserved, rural areas and eliminate barriers to care."
Click here to read "Innovations in the Plastic Surgery Care Pathway: Using Telemedicine for Clinical Efficiency and Patient Satisfaction"
Article: "Innovations in the Plastic Surgery Care Pathway: Using Telemedicine for Clinical Efficiency and Patient Satisfaction" (doi: 10.1097/PRS.0000000000005884)
About Plastic and Reconstructive Surgery
For more than 70 years, Plastic and Reconstructive Surgery® has been the one consistently excellent reference for every specialist who uses plastic surgery techniques or works in conjunction with a plastic surgeon. The official journal of the American Society of Plastic Surgeons, Plastic and Reconstructive Surgery® brings subscribers up-to-the-minute reports on the latest techniques and follow-up for all areas of plastic and reconstructive surgery, including breast reconstruction, experimental studies, maxillofacial reconstruction, hand and microsurgery, burn repair, and cosmetic surgery, as well as news on medico-legal issues.
The American Society of Plastic Surgeons (ASPS) is the world's largest organization of board-certified plastic surgeons. Representing more than 8,000 member surgeons, the Society is recognized as a leading authority and information source on aesthetic and reconstructive plastic surgery. ASPS comprises more than 93 percent of all board-certified plastic surgeons in the United States. Founded in 1931, the Society represents physicians certified by The American Board of Plastic Surgery or The Royal College of Physicians and Surgeons of Canada. ASPS advances quality care to plastic surgery patients by encouraging high standards of training, ethics, physician practice and research in plastic surgery.
About Wolters Kluwer
Wolters Kluwer is a global leader in professional information services. Professionals in the areas of legal, business, tax, accounting, finance, audit, risk, compliance and healthcare rely on Wolters Kluwer's market leading information-enabled tools and software solutions to manage their business efficiently, deliver results to their clients, and succeed in an ever more dynamic world.
Wolters Kluwer reported 2015 annual revenues of €4.2 billion. The group serves customers in over 180 countries, and employs over 19,000 people worldwide. The company is headquartered in Alphen aan den Rijn, the Netherlands. Wolters Kluwer shares are listed on Euronext Amsterdam (WKL) and are included in the AEX and Euronext 100 indices. Wolters Kluwer has a sponsored Level 1 American Depositary Receipt program. The ADRs are traded on the over-the-counter market in the U.S. (WTKWY).
Wolters Kluwer Health is a leading global provider of information and point of care solutions for the healthcare industry. For more information about our products and organization, visit www.wolterskluwer.com, follow @WKHealth or @Wolters_Kluwer on Twitter, like us on Facebook, follow us on LinkedIn, or follow WoltersKluwerComms on YouTube.